RGEN
Repligen Corp (RGEN)
Healthcare • NASDAQ • $123.46-2.35%
- Symbol
- RGEN
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $123.46
- Daily Change
- -2.35%
- Market Cap
- $6.96B
- Trailing P/E
- 135.67
- Forward P/E
- 48.36
- 52W High
- $175.77
- 52W Low
- $109.50
- Analyst Target
- $179.78
- Dividend Yield
- N/A
- Beta
- 1.09
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OP…
Company websiteResearch RGEN on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.